Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Capital Expenditures (2023 - 2024)

Exozymes (EXOZ) has disclosed Capital Expenditures for 2 consecutive years, with $210406.0 as the latest value for Q4 2024.

  • Quarterly Capital Expenditures rose 91.73% to $210406.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $396451.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $169917.0 for FY2025, 57.14% down from the prior year.
  • Capital Expenditures for Q4 2024 was $210406.0 at Exozymes, up from $37237.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $210406.0 in Q4 2024, with the low at $37237.0 in Q2 2024.